{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:53:43Z","timestamp":1744206823732,"version":"3.30.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ajg.2024.07.013","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T11:20:56Z","timestamp":1726485656000},"page":"378-382","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["High frequency of anti-Saccharomyces cerevisiae antibodies in chronic hepatitis C"],"prefix":"10.1016","volume":"25","author":[{"given":"Mariam","family":"Ghozzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amani","family":"Mankai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Mechi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeineb","family":"Ben Chedly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ouafa","family":"Kallala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarra","family":"Melayah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelhalim","family":"Trabelsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtissem","family":"Ghedira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ajg.2024.07.013_b0005","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.3390\/ijms232012661","article-title":"Role of intestinal microbes in chronic liver diseases","volume":"23","author":"Xu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajg.2024.07.013_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.712105","article-title":"Chronic hepatitis C pathogenesis: immune response in the liver microenvironment and peripheral compartment","volume":"11","author":"Rios","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"5","key":"10.1016\/j.ajg.2024.07.013_b0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","article-title":"Targeting the gut-liver axis in liver disease","volume":"67","author":"Wiest","year":"2017","journal-title":"J Hepatol"},{"issue":"8","key":"10.1016\/j.ajg.2024.07.013_b0020","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.3390\/v14081811","article-title":"Characterization of the intestinal fungal microbiome in HIV and HCV mono-infected or Co-infected patients","volume":"14","author":"Yin","year":"2022","journal-title":"Viruses"},{"issue":"33","key":"10.1016\/j.ajg.2024.07.013_b0025","doi-asserted-by":"crossref","first-page":"5488","DOI":"10.3748\/wjg.v27.i33.5488","article-title":"Microbiota and viral hepatitis: State of the art of a complex matter","volume":"27","author":"Milosevic","year":"2021","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.ajg.2024.07.013_b0030","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.3390\/jcm11195936","article-title":"The role of the microbiota gut-liver axis during HCV chronic infection: a schematic overview","volume":"11","author":"Marascio","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.11613\/BM.2013.006","article-title":"Serological markers of inflammatory bowel disease","volume":"23","author":"Kuna","year":"2013","journal-title":"Biochem Med (Zagreb)"},{"issue":"5","key":"10.1016\/j.ajg.2024.07.013_b0040","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","article-title":"The value of serologic markers in indeterminate colitis: a prospective follow-up study","volume":"122","author":"Joossens","year":"2002","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.ajg.2024.07.013_b0045","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.1038\/ctg.2018.1","article-title":"Antibodies against glycoprotein 2 display diagnostic advantages over ASCA in distinguishing CD from intestinal tuberculosis and intestinal Beh\u00e7et\u2019s disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Clin Transl Gastroenterol"},{"issue":"8","key":"10.1016\/j.ajg.2024.07.013_b0050","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1136\/gut.2003.030734","article-title":"Anti-Saccharomyces cerevisiae antibody (ASCA) positivity is associated with increased risk for early surgery in Crohn's disease","volume":"53","author":"Forcione","year":"2004","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/MPG.0000000000002311","article-title":"Anti-saccharomyces cerevisiae antibodies as a prognostic biomarker in children with crohn disease","volume":"69","author":"Chandrakumar","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"7","key":"10.1016\/j.ajg.2024.07.013_b0060","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/00365520601154996","article-title":"Anti-Saccharomyces cerevisiae antibodies in coeliac disease","volume":"42","author":"Toumi","year":"2007","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.ajg.2024.07.013_b0065","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s10620-007-0092-y","article-title":"Anti-Saccharomyces cerevisiae antibodies in primary biliary cirrhosis","volume":"53","author":"Sakly","year":"2008","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.ajg.2024.07.013_b0070","first-page":"108","article-title":"Anti-Saccharomyces cerevisiae antibodies are frequent in type 1 diabetes","volume":"21","author":"Sakly","year":"2010","journal-title":"EndocrPathol"},{"issue":"3","key":"10.1016\/j.ajg.2024.07.013_b0075","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00296-012-2431-3","article-title":"Anti-Saccharomyces cerevisiae antibodies in patients with systemic lupus erythematosus","volume":"33","author":"Manka\u00ef","year":"2013","journal-title":"Rheumatol Int"},{"issue":"2","key":"10.1016\/j.ajg.2024.07.013_b0080","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/07435800.2012.723293","article-title":"Anti-Saccharomyces cerevisiae antibodies are elevated in Graves' disease but not in Hashimoto's thyroiditis","volume":"38","author":"Manka\u00ef","year":"2013","journal-title":"Endocr Res"},{"issue":"6","key":"10.1016\/j.ajg.2024.07.013_b0085","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/jcla.21942","article-title":"Anti Saccharomycescerevisiae antibodies in patients with anti-\u03b22 glycoprotein I antibodies","volume":"30","author":"Manka\u00ef","year":"2016","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"10.1016\/j.ajg.2024.07.013_b0090","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/labmed\/lmac054","article-title":"Anti-Saccharomyces cerevisiae antibodies in rheumatoid arthritis","volume":"53","author":"Melayah","year":"2022","journal-title":"Lab Med"},{"issue":"10","key":"10.1016\/j.ajg.2024.07.013_b0095","doi-asserted-by":"crossref","first-page":"e033880","DOI":"10.1136\/bmjopen-2019-033880","article-title":"Meta-analysis of anti-Saccharomyces cerevisiae antibodies as diagnostic markers of Beh\u00e7et's disease with gastrointestinal involvement","volume":"10","author":"Cheng","year":"2020","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.ajg.2024.07.013_b0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajg.2022.07.001","article-title":"Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19","volume":"23","author":"Melayah","year":"2022","journal-title":"Arab J Gastroenterol"},{"issue":"29","key":"10.1016\/j.ajg.2024.07.013_b0105","doi-asserted-by":"crossref","first-page":"8749","DOI":"10.12998\/wjcc.v9.i29.8749","article-title":"Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality","volume":"9","author":"Ronderos","year":"2021","journal-title":"World J Clin Cases"},{"issue":"9","key":"10.1016\/j.ajg.2024.07.013_b0110","doi-asserted-by":"crossref","first-page":"e12957","DOI":"10.1371\/journal.pone.0012957","article-title":"Presence of anti-microbial antibodies in liver cirrhosis\u2013a tell-tale sign of compromised immunity?","volume":"5","author":"Papp","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/liv.13485","article-title":"Intestinal microbiota in patients with chronic hepatitis C with and without cirrhosis compared with healthy controls","volume":"38","author":"Heidrich","year":"2018","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0120","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","article-title":"Gut microbiome alterations in patients with stage 4 hepatitis C","volume":"8","author":"Aly","year":"2016","journal-title":"Gut Pathog"},{"issue":"9","key":"10.1016\/j.ajg.2024.07.013_b0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","article-title":"Gut microbiota changes and chronic hepatitis C virus infection","volume":"11","author":"Preveden","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41575-022-00663-1","article-title":"Gut immune cell trafficking: inter-organ communication and immune-mediated inflammation","volume":"20","author":"Zundler","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.ajg.2024.07.013_b0135","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrgastro.2014.188","article-title":"Mycobiota in gastrointestinal diseases","volume":"12","author":"Mukherjee","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jcmgh.2020.08.009","article-title":"Safety and efficacy of avaren-Fc lectibody targeting HCV high-mannose glycans in a human liver chimeric mouse model","volume":"11","author":"Dent","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.ajg.2024.07.013_b0145","doi-asserted-by":"crossref","first-page":"e01403","DOI":"10.1128\/JVI.01403-18","article-title":"Antigenicity and immunogenicity of differentially glycosylated hepatitis C virus E2 envelope proteins expressed in mammalian and insect cells","volume":"93","author":"Urbanowicz","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.ajg.2024.07.013_b0150","article-title":"Macrophage activation markers, soluble CD163 and mannose receptor, in liver fibrosis","volume":"7","author":"Gantzel","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.ajg.2024.07.013_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.587669","article-title":"Low mannose binding lectin, but not L-ficolin, is associated with spontaneous clearance of hepatitis C virus after infection","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.ajg.2024.07.013_b0160","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.kint.2020.05.013","article-title":"The case of complement activation in COVID-19 multiorgan impact","volume":"98","author":"Noris","year":"2020","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.ajg.2024.07.013_b0165","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1530\/eje.1.02013","article-title":"Thyroid hormone increases mannan-binding lectin levels","volume":"153","author":"Riis","year":"2005","journal-title":"Eur J Endocrinol"},{"issue":"10","key":"10.1016\/j.ajg.2024.07.013_b0170","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1210\/jc.2003-030742","article-title":"Elevated levels of mannan-binding lectin in patients with type 1 diabetes","volume":"88","author":"Hansen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.ajg.2024.07.013_b0175","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/jaut.2001.0538","article-title":"Single nucleotide polymorphisms of the mannose-binding lectin are associated with susceptibility to primary biliary cirrhosis","volume":"17","author":"Matsushita","year":"2001","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.ajg.2024.07.013_b0180","first-page":"1692","article-title":"Patients with rheumatoid arthritis have higher levels of mannan-binding lectin than their first-degree relatives and unrelated controls","volume":"34","author":"Saevarsdottir","year":"2007","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.ajg.2024.07.013_b0185","doi-asserted-by":"crossref","first-page":"R218","DOI":"10.1186\/ar4057","article-title":"Mannose binding lectin: a biomarker of systemic lupus erythematosus disease activity","volume":"14","author":"Panda","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ajg.2024.07.013_b0190","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1196\/annals.1422.051","article-title":"Cross-reactive epitopes on beta2-glycoprotein-I and Saccharomyces cerevisiae in patients with the antiphospholipid syndrome","volume":"1108","author":"Krause","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0195","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ajg.2021.12.003","article-title":"IgA anti-beta-2 glycoprotein I antibodies in chronic hepatitis C","volume":"23","author":"Melayah","year":"2022","journal-title":"Arab J Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2024.07.013_b0200","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/21505594.2016.1247140","article-title":"Fungi in the healthy human gastrointestinal tract","volume":"8","author":"Hallen-Adams","year":"2017","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.ajg.2024.07.013_b0205","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jhep.2022.12.006","article-title":"Fungal infections and the fungal microbiome in hepatobiliary disorders","volume":"78","author":"Hartmann","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajg.2024.07.013_b0210","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-230X-12-155","article-title":"Candidiasis and other oral mucosal lesions during and after interferon therapy for HCV-related chronic liver diseases","volume":"12","author":"Nagao","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"10.1016\/j.ajg.2024.07.013_b0215","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4103\/1319-3767.41736","article-title":"Peritonitis due to Candida albicans in a patient with chronic hepatitis C infection","volume":"14","author":"Chakravarty-Vartak","year":"2008","journal-title":"Saudi J Gastroenterol"},{"issue":"6","key":"10.1016\/j.ajg.2024.07.013_b0220","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hep.30087","article-title":"Binding of free and immune complex-associated hepatitis C virus to erythrocytes is mediated by the complement system","volume":"68","author":"Salam","year":"2018","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ajg.2024.07.013_b0225","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cmi.2021.07.034","article-title":"The human gut mycobiome and the specific role of Candida albicans: where do we stand, as clinicians?","volume":"28","author":"Musumeci","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.ajg.2024.07.013_b0230","doi-asserted-by":"crossref","first-page":"e66019","DOI":"10.1371\/journal.pone.0066019","article-title":"Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents","volume":"8","author":"Hoffmann","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ajg.2024.07.013_b0235","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bpg.2015.05.004","article-title":"Celiac disease from a global perspective","volume":"29","author":"Lionetti","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"15","key":"10.1016\/j.ajg.2024.07.013_b0240","doi-asserted-by":"crossref","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","article-title":"Global increase and geographic convergence in antibiotic consumption between 2000 and 2015","volume":"115","author":"Klein","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.ajg.2024.07.013_b0245","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1007\/s00705-019-04308-8","article-title":"Hepatitis C virus epidemiology in Central-West Tunisia: a population-based cross-sectional study","volume":"164","author":"Bettaieb","year":"2019","journal-title":"Arch Virol"}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197924000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197924000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T09:08:32Z","timestamp":1732957712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197924000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1687197924000753"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2024.07.013","relation":{},"ISSN":["1687-1979"],"issn-type":[{"type":"print","value":"1687-1979"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High frequency of anti-Saccharomyces cerevisiae antibodies in chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2024.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}